Evidence map›Paper›PMID 22241526›Full record

ArticleMutagenesis2012

Undetectable role of oxidative DNA damage in cell cycle, cytotoxic and clastogenic effects of Cr(VI) in human lung cells with restored ascorbate levels.

Mindy Reynolds, Susan Armknecht, Tatiana Johnston, Anatoly Zhitkovich

Open access · greenAbstract read
In one paragraph

Article in Mutagenesis, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Chemical mechanisms of DNA damage by carcinogenic chromium(VI).Advances in pharmacology (San Diego, Calif.) · 2023
    Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Mindy ReynoldsDepartment of Pathology and Laboratory Medicine, Brown University, Providence, RI 02912, USA.
Susan Armknecht
Tatiana Johnston
Anatoly Zhitkovich
Brown University · US

Funding

Vapor Pressures and Thermodynamic Properties of Complex Organic MixturesP42ES013660 · NIEHS · BROWN UNIVERSITY · PI BOEKELHEIDE, KIM · 2005 to 2020
$37.7M
GENOTOXICITY OF CHROMIUM COMPOUNDSR01ES008786 · NIEHS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ZHITKOVICH, ANATOLY · 1997 to 2019
$5.7M
NIEHS NIH HHS P42 ES013660NIEHS NIH HHS R01 ES008786
6 · The paper itself

Abstract

Cultured human cells are invaluable biological models for mechanistic studies of genotoxic chemicals and drugs. Continuing replacement of animals in toxicity testing will further increase the importance of in vitro cell systems, which should accurately reproduce key in vivo characteristics of toxicants such as their profiles of metabolites and DNA lesions. In this work, we examined how a common severe deficiency of cultured cells in ascorbate (Asc) impacts the formation of oxidative DNA damage by hexavalent chromium (chromate). Cr(VI) is reductively activated inside the cells by both Asc and small thiols but with different rates and spectra of intermediates and DNA adducts. We found that Cr(VI) exposure of H460 human lung epithelial cells in standard culture (<0.01 mM cellular Asc) induced biologically significant amounts of oxidative DNA damage. Inhibition of oxidative damage repair in these cells by stable XRCC1 knockdown strongly enhanced cytotoxic effects of Cr(VI) and led to depletion of cells from G(1) and accumulation in S and G(2) phases. However, restoration of physiological levels of Asc (≈ 1 mM) completely eliminated Cr(VI) hypersensitivity of XRCC1 knockdown. The induction of chromosomal breaks assayed by the micronucleus test in Asc-restored H460, primary human lung fibroblasts, and CHO cells was also unaffected by the XRCC1 status. Centromere-negative (clastogenic) micronuclei accounted for 80-90% of all Cr(VI)-induced micronuclei. Consistent with the micronuclei results, Asc-restored cells also showed no increase in the levels of poly(ADP-ribose), which is a biochemical marker of single-stranded breaks. Asc had no effect on cytotoxicity of O(6)-methylguanine, a lesion produced by direct DNA alkylation. Overall, our results indicate that the presence of physiological levels of Asc strongly suppresses pro-oxidant pathways in Cr(VI) metabolism and that the use of standard cell cultures creates a distorted profile of its genotoxic properties.

Indexed as

AnimalsAntioxidantsAscorbic AcidBlotting, WesternCarcinogens, EnvironmentalCell CycleCell DeathCells, CulturedChromatography, High Pressure LiquidChromiumCricetinaeCricetulusDNA AdductsDNA-Binding ProteinsDNA DamageDNA RepairAntioxidantsAscorbic AcidCarcinogens, EnvironmentalChromiumchromium hexavalent ionDNA AdductsDNA-Binding ProteinsGlutathioneGuanineO-(6)-methylguanineReactive Oxygen SpeciesRNA, Small InterferingX-ray Repair Cross Complementing Protein 1XRCC1 protein, human

Identifiers

PMID22241526
PMCPMC3382305
OpenAlexW2155728687

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.